Gardie, B., Remenieras, A., Kattygnarath, D., Bombled, J., Lefèvre, S., Perrier-Trudova, V., Rustin, P., Barrois, M., Slama, A., Avril, M., Bessis, D., Caron, O., Caux, F., Collignon, P., Coupier, I., Cremin, C., Dollfus, H., Dugast, C., Escudier, B., Faivre, L., Field, M., Gilbert-Dussardier, B., Janin, N., Leport, Y., Leroux, D., Lipsker, D., Malthieu, F., McGilliwray, B., Maugard, C., Méjean, A., Mortemousque, I., Plessis, G., Poppe, B., Pruvost-Balland, C., Rooker, S., Roume, J., Soufir, N., Steinraths, M., Tan, M., Théodore, C., Thomas, L., Vabres, P., Van Glabeke, E., Meric, J., Verkarre, V., Lenoir, G., Joulin, V., Deveaux, S., Cusin, V., Feunteun, J., Teh, B. T., Paillerets, B. B., & Richard, S. (2011). novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. Journal of medical genetics, 48(4), 226–234. http://access.bl.uk/ark:/81055/vdc_100137792880.0x000040